Table 1

Cardiovascular disease in patients with rheumatoid arthritis currently and previously using antimalarials

Currently users of antimalarialsPrevious users of antimalarials withdrawn by adverse events
ComorbiditiesCLQ
(n=583)
HCLQ (n=77)Total n=660 (%)CLQ
(n=330)
HCLQ (n=14)Total n=344 (%)
PH14016156 (23.5)74175 (21.8)
CVD10414 (2.1)303 (0.9)
PH and CVD15116 (2.4)16117 (4.9)
No CVD/PH comorbidities41856474 (72.0)23712249 (72.4)
  • CLQ, chloroquine; CVD, cardiovascular disease; HCLQ, hydroxychloroquine;PH, primary hypertension.